Skip to main content

Pregabalin

NDC 47335-693 · Sun Pharmaceutical Industries, Inc.

Generic namePregabalin
Dosage formCAPSULE
RouteORAL
Active ingredient(s)PREGABALIN
Strength300 mg/1
DEA scheduleCV
Marketing categoryANDA

Packages

47335-693-08 — 100 CAPSULE in 1 BOTTLE (47335-693-08)

47335-693-18 — 1000 CAPSULE in 1 BOTTLE (47335-693-18)

47335-693-83 — 30 CAPSULE in 1 BOTTLE (47335-693-83)

47335-693-88 — 100 CAPSULE in 1 BOTTLE (47335-693-88)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

46708-124 — Pregabalin, 46708-125 — Pregabalin, 46708-126 — Pregabalin, 47335-686 — Pregabalin, 47335-687 — Pregabalin, 47335-688 — Pregabalin, 47335-689 — Pregabalin, 47335-690 — Pregabalin, 47335-691 — Pregabalin, 47335-692 — Pregabalin, 50090-5038 — PREGABALIN, 50090-5071 — Pregabalin, 50090-6503 — Pregabalin, 50090-6504 — Pregabalin, 50090-6793 — PREGABALIN, 50090-7983 — Pregabalin, 50228-350 — PREGABALIN, 50228-351 — PREGABALIN, 50228-352 — PREGABALIN, 50228-353 — PREGABALIN, +519 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels